Literature DB >> 10356313

A polymorphic variant in the human electron transfer flavoprotein alpha-chain (alpha-T171) displays decreased thermal stability and is overrepresented in very-long-chain acyl-CoA dehydrogenase-deficient patients with mild childhood presentation.

P Bross1, P Pedersen, V Winter, M Nyholm, B N Johansen, R K Olsen, M J Corydon, B S Andresen, H Eiberg, S Kolvraa, N Gregersen.   

Abstract

The consequences of two amino acid polymorphisms of human electron transfer flavoprotein (alpha-T/I171 in the alpha-subunit and beta-M/T154 in the beta-subunit) on the thermal stability of the enzyme are described. The alpha-T171 variant displayed a significantly decreased thermal stability, whereas the two variants of the beta-M/T154 polymorphism did not differ. We wished to test the hypothesis that these polymorphisms might constitute susceptibility factors and therefore determined their allele and genotype frequencies in (i) control individuals, (ii) medium-chain acyl-CoA dehydrogenase-deficient patients homozygous for the K304E mutation (MCAD E304), (iii) a group of patients with elevated urinary excretion of ethylmalonic acid (EMA) possibly due to decreased short-chain acyl-CoA dehydrogenase activity, and (iv) in patients with proven deficiency of very-long-chain acyl-CoA dehydrogenase (VLCAD). No significant overrepresentations or underrepresentations were found in the first two patient groups, suggesting that the polymorphisms studied are not significant susceptibility factors in either the MCAD E304 or the EMA patient group. However, in the VLCAD deficient patients the alpha-T171 variant (decreased thermal stability) was significantly overrepresented. Subgrouping of the VLCAD patients into three phenotypic classes (severe childhood, mild childhood, and adult presentation) revealed that the overrepresentation of the alpha-T171 variant was significant only in patients with mild childhood presentation. This is compatible with a negative modulating effect of the less-stable alpha-T171 ETF variant in this group of VLCAD patients that harbor missense mutations in at least one allele and therefore potentially display residual levels of VLCAD enzyme activity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356313     DOI: 10.1006/mgme.1999.2856

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

1.  Gene assignment in Ateles paniscus chamek (Platyrrhini, Primates). Allocation of 18 markers of human syntenic groups 1, 2, 7, 14, 15, 17 and 22.

Authors:  H N Seuánez; C R Lima; B Lemos; C R Bonvicino; M A Moreira; F C Canavez
Journal:  Chromosome Res       Date:  2001       Impact factor: 5.239

Review 2.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

Review 3.  Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease.

Authors:  Bárbara J Henriques; Rikke Katrine Jentoft Olsen; Cláudio M Gomes; Peter Bross
Journal:  Gene       Date:  2021-01-13       Impact factor: 3.688

4.  Genome-wide association study identifies multiple susceptibility loci for glioma.

Authors:  Ben Kinnersley; Marianne Labussière; Amy Holroyd; Anna-Luisa Di Stefano; Peter Broderick; Jayaram Vijayakrishnan; Karima Mokhtari; Jean-Yves Delattre; Konstantinos Gousias; Johannes Schramm; Minouk J Schoemaker; Sarah J Fleming; Stefan Herms; Stefanie Heilmann; Stefan Schreiber; Heinz-Erich Wichmann; Markus M Nöthen; Anthony Swerdlow; Mark Lathrop; Matthias Simon; Melissa Bondy; Marc Sanson; Richard S Houlston
Journal:  Nat Commun       Date:  2015-10-01       Impact factor: 14.919

5.  Role of METTL20 in regulating β-oxidation and heat production in mice under fasting or ketogenic conditions.

Authors:  Tadahiro Shimazu; Tamio Furuse; Shabeesh Balan; Ikuko Yamada; Shuzo Okuno; Hiroko Iwanari; Takehiro Suzuki; Takao Hamakubo; Naoshi Dohmae; Takeo Yoshikawa; Shigeharu Wakana; Yoichi Shinkai
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

6.  Oxidation of the FAD cofactor to the 8-formyl-derivative in human electron-transferring flavoprotein.

Authors:  Peter Augustin; Marina Toplak; Katharina Fuchs; Eva Christine Gerstmann; Ruth Prassl; Andreas Winkler; Peter Macheroux
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

7.  Hyperammonemia after capecitabine associated with occult impairment of the urea cycle.

Authors:  Gilbert Chu; Julia Salzman
Journal:  Cancer Med       Date:  2019-04-11       Impact factor: 4.452

8.  Interaction of glutaric aciduria type 1-related glutaryl-CoA dehydrogenase with mitochondrial matrix proteins.

Authors:  Jessica Schmiesing; Hartmut Schlüter; Kurt Ullrich; Thomas Braulke; Chris Mühlhausen
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 9.  Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.

Authors:  Signe Mosegaard; Graziana Dipace; Peter Bross; Jasper Carlsen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.